Internal Medicine CME Learning Center | Education on Internal Medicine

Search

All France Foundation Content

Page 4 of 4

Results 226 - 285 of 285

From Bench to Bedside: Gene Therapy Approaches for Rare Diseases

Biosimilars: Applying the Science to Hematology/Oncology Practice

The Latest from a Recent Pulmonary Conference in San Antonio

Updates in Inoperable CTEPH

The Importance of Early Integration of Palliative Care

Management of IPF Patients in 2018

Updates in the Diagnosis of ILD and the Role of Cryobiopsy

Overview of the Latest Clinical Trials in IPF

Evolution of Antifibrotic Therapy in IPF

Take Home Messages from the 2018 CHEST Annual Meeting

What We’re Learning from the IPF-PRO Registry

Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines

What’s New in Spinal Muscular Atrophy? Reporting from Dallas

Atopic Dermatitis: Putting it Together (Dermatology)

Atopic Dermatitis: Putting it Together (Primary Care)

atopic-derm2 copy

Atopic Dermatitis: Recent and Emerging Therapies

An Introduction to Atopic Dermatitis

SMA Updates from Los Angeles

PAH Today: Mastering Current, Tailored Treatment

Achieving Better Control of Severe Asthma

asthma-uncontrol icon

A Personalized Approach to Managing Uncontrolled Asthma

Updates in SMA and Gene Therapy from Arlington, VA

Proper_Use_of_an_Inhaler_264x150

Proper Use of an Inhaler

psoriasis-nurse

Psoriasis Management Considerations: What Would You Do?

psoriasis-case3

Jamie Develops Complications with Her Psoriasis

psoriasis-case2

Psoriasis: Three Case Studies in the Primary Care Setting

psoriasis-case1

Cindy Has a Complex Case of Psoriasis

Famous People with Diabetes: Ella Fitzgerald

Famous People with Diabetes: Jerry Garcia

Targeting B-cells in Primary Progressive MS (PPMS)

Comorbidities and Selection of DMTs

The Gut Microbiota in MS

Early MS: Induction Therapy and Escalation Strategies

Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS

t2diabetes-slides1

Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options

t2diabetes-slides2

Download Slides: Advancing T2DM Therapy with Confidence

t2diabetes-louise

Getting to Goal Can Be Difficult: Louise

t2diabetes-brian

Getting to Goal Can Be Difficult: Brian

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

IL-gastro-case3

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

IL-gastro-case2

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

IL-gastro-case1

Innovator or Biosimilar for a Patient with Ulcerative Colitis?

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Innovator or Biosimilar for a Patient with Psoriasis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Are You Ready to Use Biosimilars in Your Practice?

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Addressing Common Barriers to Adherence

Page 4 of 4

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA